Figure 3From: Disease control and functional outcome in three modern combined organ preserving regimens for locally advanced squamous cell carcinoma of the head and neck (SCCHN)Overall survival. 0: RChT; 1: TPF; 2: RIT. RChT median: 22.8 months [95%-CI: 13.1 - 40.9]; OS @ 2 years: 48.7%. TPF median: not reached; OS @ 2 years: 79.3%. RIT median: 27.7 months [95%-CI: 12.6 - 33.9]; OS @ 2 years: 50%. RChT vs TPF: logrank 0.05, Wilcoxon 0.067. RChT vs RIT: ns. RIT vs TPF: ns.Back to article page